One year on, UPC finally publishes pleadings – revealing ongoing problems with transparency of proceedings
This article had been covered by IP Fray Law360 and World IP Review (WIPR) On 21 November 2023, Mathys & Squire lodged a request under Rule 2621(b) of the UPC’s Rules of Procedure… read more…
UK ranks highly in European university innovation study
A recent report by the European Patent Office [1] has revealed that 10% of all inventions for which a European patent application has been filed are generated by university research conducted in… read more…
Change in European law rescues ‘same applicant’ priority in important CRISPR patents
About a year ago, the Enlarged Board of Appeal issued its decision in G 1/22 (consolidated with G 2/22), which significantly relaxed the EPO’s approach to ‘same applicant’ priority Under… read more…
Semiconductor patent applications up 22% globally to 81,000 a year
Commentary by Partner Edd Cavanna has been featured in Law360, World Intellectual Property Review, The Register and Communications Today discussing the global increase of semiconductor patent… read more…
Emerging therapeutics and technology provide hope for menopause management
Historically, women’s health has been greatly underfunded and under-researched Nowhere is this gender-biased neglect more evident than in the research and clinical management of menopause symptoms… read more…
Mathys & Squire ranked in Chambers & Partners Guide for 2025
Mathys & Squire have ranked in the 2025 Chambers and Partners UK Legal Guide, which acknowledges some of the top ranked law firms and lawyers each year The research analysts obtain information… read more…
EPO Board of Appeal finds no basis in EPC for requiring description amendments, and opts not to refer questions to the Enlarged Board
In a much-anticipated decision, Technical Board of Appeal 3304 has held that there is no requirement under the EPC for an applicant to amend the description of a patent application before grant (T… read more…
Two CRISPR patents pulled from EPO appeals citing procedural concerns
In a surprise move, the representatives acting on behalf of UC Berkley defending CRISPR patents in appeal proceedings before the EPO have withdrawn their approval of the texts of the patents thereby… read more…
Mathys & Squire teams recommended in The Legal 500 2025 directory for their “unparalleled knowledge and experience in all areas of intellectual property”
We are delighted to announce that Mathys & Squire has upheld its position in the 2025 edition of The Legal 500 for both PATMA: Patent Attorneys and PATMA: Trade Mark Attorneys categories… read more…
